Table of Contents
1 Table Of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2
Executive Summary 7
3 Coronary Stents Market Overview 8
3.1
Introduction and Definition 8
3.1.1 Coronary Stents 8
3.1.1.1 Bare
Metal Stents 8
3.1.1.2 Drug Eluting Coronary Stents 8
3.2 Market
Overview 9
3.2.1 Risk Factors for Coronary Disease 12
3.3 Cross
Category Analysis 13
3.3.1 US Interventional Cardiology Market Cross
Category Analysis (2001-2015) 13
3.4 Competitive Landscape 14
3.5 The
US Coronary Stents Market: Trend Analysis 16
3.5.1 Market Snapshot 16
3.5.2 Emergence of DES - Overview 16
3.5.2.1 Drug Eluting Stent (DES)
Market: Drivers 17
3.5.2.2 Drug Eluting Stents (DES) Market: Restraints
18
3.5.3 Stent Coatings 18
3.5.4 Stent Implantation Procedure –
Overview 19
3.5.5 Key End Users 20
3.5.6 The US Coronary Stent Market:
Drivers 20
3.5.6.1 Increased obesity rates in some population groups
enhances the demand for Percutaneous Coronary Intervention (PCI) 20
3.5.6.2 Developments in Imaging Enhanced Accuracy of Implantation and Surgical
Procedures 21
3.5.6.3 The Next Generation of Hybrid Devices Could Increase
Treatment Outcome and Device Applicability 21
3.5.7 The US Coronary Stents
Market: Restraints 21
3.5.7.1 Negative promotion activities related to
stents market have affected the usage of DES 21
3.5.7.2 High price of
treating cardiovascular diseases results in more economics based decision
making on the part of healthcare providers 22
3.5.8 Emerging Technologies
in the US Coronary Stents Market 23
3.5.8.1 Diamond like Carbon Coating
(DLC) 23
3.5.8.2 Advanced Drug eluting coatings 23
3.5.8.3
Bioabsorbable Stents 23
3.5.8.4 Platinum Enriched Stainless Steel (PERSE)
25
3.5.8.5 Antibody coated or gene therapy stents 25
3.6 Future
Outlook and Implications: US Coronary Stents Market 25
4 Mergers &
Acquisitions 26
4.1 Mergers & Acquisitions in 2009 26
4.1.1 Boston
Scientific Acquires Labcoat 26
4.2 Mergers & Acquisitions in 2007 26
4.2.1 Medtronic Acquires Setagon 26
4.3 Mergers & Acquisitions in 2006
26
4.3.1 Abbott Laboratories Acquires Vascular Business of Guidant From
Boston Scientific 26
5 Coronary Stent Pipeline Products 27
5.1 Key
Coronary Stents pipeline products 27
6 Appendix 41
6.1 Research
Methodology 42
6.2 Coverage 43
6.3 Secondary Research 43
6.4
Primary Research 44
6.5 Models 44
6.6 Forecasts 45
6.7 Expert
Panels 45
6.8 GlobalData Consulting 45
6.9 Contact Us 45
6.10
Disclaimer 46
1.1 List of Tables
Table 1: Coronary Stent Market,
US, Overall Revenue ($ mn), Historic, 2001 – 2008 11
Table 2:
Coronary Stent Market, US, Overall Revenue ($ mn), Forecast, 2008 – 2015
12
Table 3: Company Shares in the US Coronary Stents Market ($ mn) and
(%), 2007 15
Table 4: Drug-Eluting Stents Comparison 17
Table 5:
Coatings on Drug Eluting Stents 19
Table 6: Key Companies with
Bioabsorbable Stents in Pipeline 24
Table 7: Coronary Stent Pipeline
Products By Equipment Type 27
Table 8: Coronary Stent Pipeline Products By
Development Stage 31
Table 9: Coronary Stent Pipeline Products By Therapy
Area 35
1.2 List of Figures
Figure 1: Coronary Stents Market
Definition, US, 2008 8
Figure 2: Segment Contribution By Type Of Coronary
Stent Market (%), US, 2008 10
Figure 3: Coronary Stent Market, US, Overall
Revenue ($ mn), 2001 – 2015 11
Figure 4: US Interventional
Cardiology Market Cross Category Analysis (2001-2015) 13
Figure 5: Company
Share in the US Coronary Stents Market (%), 2007 14
Figure 6: History of
Coronary Artery Disease Prevention, US, 2008 16
Figure 7: Diagrammatic
Representation of Artery Before and After Placing the Stent 20
Figure 8:
Drivers and Restraints in the US Coronary Stent Market 22
Figure 9:
GlobalData Methodology 42
| 
View Cart
